Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia

Pukhraj Rishi; Ekta Rishi; Daraius Shroff

首页> 外文期刊>Indian Journal of Ophthalmology >Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia

【24h】

Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia

机译：结合光动力疗法和玻璃体内贝伐单抗作为与2型特发性黄斑毛细血管扩张相关的视网膜下新生血管的主要治疗方法

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Indian Journal of Ophthalmology》 |2009年第3期|共2页
作者
Pukhraj Rishi; Ekta Rishi; Daraius Shroff;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia [J] . Pukhraj Rishi, Daraius Shroff, Ekta Rishi Graefe's Archive for Clinical and Experimental Ophthalmology . 2008,第4期

机译：光动力疗法与玻璃体内兰尼单抗联合治疗是与2型特发性黄斑毛细血管扩张相关的视网膜下新生血管膜（SRNVM）的主要治疗方法
2. LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 [J] . Toygar Okan, Guess Matthew G., Youssef David S., Retina . 2016,第11期

机译：继发于贝伐他珠单抗治疗继发于2型特发性黄斑部球囊炎的继发于视网膜下神经结膜的长期结果
3. Intravitreal bevacizumab alone versus combined verteporfin photodynamic therapy and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration: visual acuity after 1 year of follow-up. [J] . Rudnisky CJ, Liu C, Ng M, Retina . 2010,第4期

机译：玻璃体腔内贝伐单抗单独联合维替泊芬光动力疗法与玻璃体腔内贝伐单抗联合治疗年龄相关性黄斑变性中的脉络膜新生血管：随访1年后的视力。
4. Photodynamic Therapy for Treatment Subretinal Neovascularization [C] . Sergey E. Avetisov, Maria V. Budzinskaja, Tatyana N Kiseleva, Conference on Therapeutic Laser Applications and Laser-Tissue Interactions III . 2007

机译：光动力疗法治疗视网膜下新生血管
5. Clinical Features of Treated and Untreated Type 1 Idiopathic Macular Telangiectasia Without the Occurrence of Secondary Choroidal Neovascularization Followed for 2 Years in Japanese Patients [D] . 逢坂理恵 2019

机译：在日本患者中治疗和未治疗的1型特发性黄斑部毛细血管扩张症的临床特征为继发性脉络膜新血管形成，随访2年
6. Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study [O] . Sandro Saviano, Pia Easter Leon, Alessandro Mangogna, 2016

机译：联合治疗（玻璃体内贝伐单抗加维替泊芬光动力疗法）与玻璃体内贝伐单抗单药治疗年龄相关性黄斑变性引起的脉络膜新生血管：一项为期一年的随访研究
7. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia [O] . Rishi, Pukhraj, Rishi, Ekta, Shroff, Daraius 2009

机译：结合光动力疗法和玻璃体内贝伐单抗作为与2型特发性黄斑毛细血管扩张相关的视网膜下新生血管的主要治疗方法

Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia

著录项

相似文献

相关主题

期刊订阅